Perkiomenville, PA, United States of America

Scott D Reynolds

This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignee: Merck + Co., Inc.. Active years: 1991-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Scott D Reynolds. Retrieved from https://idiyas.com/inventor/scott-d-reynolds-kv36m7n6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 26(Granted Patents)


Location History:

  • Plainsboro, NJ (US) (1991)
  • Perkiomenville, PA (US) (2002)
  • Pekiomenville, PA (US) (2003)

Company Filing History:


Years Active: 1991-2003

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Scott D Reynolds: Innovator in Antibiotic Formulation

Introduction

Scott D Reynolds is a notable inventor based in Perkiomenville, PA (US). He has made significant contributions to the field of antibiotic formulations, holding a total of 3 patents. His work is primarily associated with Merck & Company, Inc., a leading global healthcare company.

Latest Patents

Reynolds' latest patents include innovative processes for the formulation of carbapenem antibiotic compositions and antibiotic compounds. These patents reflect his commitment to advancing medical science and improving treatment options for patients.

Career Highlights

Throughout his career, Scott D Reynolds has focused on developing effective antibiotic solutions. His expertise in this area has positioned him as a valuable asset within the pharmaceutical industry.

Collaborations

Reynolds has collaborated with esteemed colleagues, including Anthony S Al-Dehneh and William A Hunke. These partnerships have further enhanced his research and development efforts.

Conclusion

Scott D Reynolds is a dedicated inventor whose work in antibiotic formulation has made a significant impact in the healthcare sector. His contributions continue to influence the development of effective treatments for various infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…